Sonorous NV Uses New Device to Treat Patients with Symptomatic Cerebral Venous Diseases

LAKE FOREST, Calif., Dec. 16, 2022 /PRNewswire/ — Sonorous NV, Inc. Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. The single-use, implantable device acts…